Successful proposals will focus on strategies, tools, technologies, and model systems that will advance the development of nonsense mutation-directed therapies for CF.
There are two program options:
|Award type||Funding level|
|Research Grant||Up to $250,000 per year plus 12% indirect costs for up to two years|
|Pilot and Feasibility Award||Up to $75,000 per year plus 12% indirect costs for up to two years|
Deadline for all applications: October 24, 2019
Applications must be submitted online at proposalCENTRAL by 5 p.m. ET.
Weblink for more information
Filed Under: Funding Opportunities